Healthcare systems in Europe have evolved dramatically over the last 10 years. Health Technology Assessment agencies have flourished in every country, substantially increasing scrutiny of devices.
Payers are garnering increasing power to the detriment of doctors. HTA, QALY, Quality of Life, economic modeling, clinical and economic effectiveness reflect the new reality in which device companies operate.
MedC. Partners’ experts assist medtech companies to efficiently overcome these new hurdles.
MedC. Partners is a consulting firm, founded in 2005, and specialized in integrated marketing, reimbursement, and regulatory for the medical device industry to facilitate entry into the European market.
MedC. Partners helps innovative medical device companies through all stages of product development to European market introduction from the initial strategic evaluation to marketing strategies and reimbursement submissions.
MedC. Partners works with start-ups, established companies, and large blue chip companies in need of expert support to build their European Market Access Strategy. Several prize-winning start-ups have benefited from MedC. Partners’ work.
MedC. Partners is a team of six seasoned executives with 15 to 20 years of hands-on experience in the medtech industry, who have built medical device markets in Europe from scratch to multimillion dollar successes.
MedC. Partners participates in many medtech events internationally, as keynote speaker or as member of the advisory board, including BioData, BioTuesday, MTI conferences, the Nice Annual Meeting, EBD conference, OneMedPlace Conference in New York City, IN3 conference and Laing and Buisson Medtech Forum.
MedC. Partners has developed a unique methodology, the MedMAP program, which allows companies to assess the reimbursement landscape in Europe and find out where a device will sell best. With the MedMAP program, MedC. Partners supports medtech companies both at the strategic level and throughout implementation with authorities and payers.